An inexpensive antifungal drug slows tumor growth and shows promise as a chemotherapy for cancer, according to a new study from the University of Texas at Austin.
Thiabendazole—an FDA-approved, generic drug taken orally that has been in clinical use for 40 years as an antifungal—is not currently used for cancer therapy.
Full story at Futurity.
More research news from top universities.
Photo credit: Hye Ji Cha